Related Experiment Video
Updated: Sep 29, 2025

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Heart Involvement in Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children: The Retrospective
Mikhail M Kostik1, Liudmila V Bregel2,3, Ilia S Avrusin1
1Hospital Pediatry Department, Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russia.
Insights
Multisystem inflammatory syndrome in children (MIS-C) can affect the heart. This study identified specific criteria, including elevated troponin or combined face swelling and D-dimer levels, to help diagnose myocardial involvement in MIS-C patients.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Heart involvement is a significant concern in children diagnosed with multisystem inflammatory syndrome associated with COVID-19 (MIS-C).
- Accurate and timely diagnosis of cardiac complications in MIS-C is crucial for effective management and treatment.
- This study aims to characterize the spectrum of cardiac manifestations in MIS-C patients.
Purpose of the Study:
- To describe the various forms of heart involvement observed in pediatric patients with MIS-C.
- To identify clinical and laboratory features associated with different types of cardiac involvement, specifically coronary artery lesions (CAL) and myocardial involvement (MI).
- To propose diagnostic criteria for identifying myocardial involvement in MIS-C.
Main Methods:
- A retrospective, multicenter cohort study included 122 pediatric patients meeting WHO and CDC criteria for MIS-C.
- Data analysis focused on categorizing heart involvement into solely CAL, solely MI, or a combination of both.
- Clinical signs, laboratory values (e.g., troponin, D-dimer, ferritin, LDH), and outcomes (e.g., shock, ICU admission) were compared across patient groups.
Main Results:
- Patients with solely CAL (8.2%) resembled Kawasaki disease, while those with solely MI (24.6%) presented with older age, elevated ferritin/LDH/D-dimer, and thrombocytopenia.
- Clinical signs associated with MI included gastrointestinal/CNS disorders, sore throat, facial swelling, splenomegaly, shock, and ICU need.
- A proposed diagnostic approach using one major criterion (troponin > 32 pg/ml) or two minor criteria (face swelling and D-dimer > 1,300 ng/ml) showed 67.5% sensitivity and 88.9% specificity for MI.
Conclusions:
- Distinct clinical and laboratory profiles differentiate coronary artery lesions from myocardial involvement in MIS-C.
- Specific criteria, including elevated troponin and combinations of D-dimer and facial swelling, can aid in diagnosing myocardial involvement.
- These criteria can be integrated into routine diagnostic protocols for MIS-C patients with suspected cardiac issues.
Objectives:
Heart involvement in multisystem inflammatory syndrome associated with COVID-19 in children (MIS-C) is a new challenging problem, requiring fast and reliable diagnostics and appropriate treatment. The aim of this study is to describe heart involvement in patients with MIS-C.
Study Design:
In this retrospective, multicenter cohort study, data of 122 patients were included. All patients met WHO and CDC criteria of MIS-C.
Results:
Various types of heart involvement in MIS-C patients were observed. Patients with solely coronary artery lesions (CAL, n = 10, 8.2%) had typical features of Kawasaki disease: younger age, thrombocytosis and normal ferritin level, without giant CA aneurysms, thrombosis, myocardial infarction, shock, and ICU admission. Patients with solely myocardial involvement (MI, n = 30, 24.6%) had an older onset age, elevated ferritin, LDH, the highest D-dimer, H score, and thrombocytopenia level. The following clinical signs were associated with MI: gastrointestinal and central nervous system disorder, sore throat, swelling face, splenomegaly, shock, and treatment in the intensive care unit required. Patients with a combination of CAL and MI (n = 10, 8.2%) had symptoms similar to patients with solely MI, except for impressive thrombocytopenia. Shock and ICU admission were found in 34.7% of patients without heart involvement (n = 72, 59%). One major criterion [troponin > 32 pg/ml (52 points)] or at least two minor criteria [face swelling (32 points) and D-Dimer > 1,300 ng/ml (29 points)] were associated with MI (>32 points) with a sensitivity of 67.5% and a specificity of 88.9%.
Conclusion:
The above-suggested criteria can be added to routine diagnostic procedures to confirm MI in MIS-C patients.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Rheumatic Heart Disease I: Introduction
Myocarditis III: Medical Management
Pericarditis I: Introduction

